NEFL and hippocampal atrophy: Moreover, combining plasma p-tau181 and evidence of hippocampal atrophy from structural MRI with or without evidence of plasma NFL elevation, which showed very high specificity (98% and 96%), can increase confidence in choosing drug-candidate patients.